Breaking News Instant updates and real-time market news.

CBS

CBS

$60.06

-0.87 (-1.43%)

, ANF

Abercrombie & Fitch

$15.19

-0.3 (-1.94%)

10:08
11/23/16
11/23
10:08
11/23/16
10:08

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CBS (CBS) downgraded to Market Perform from Outperform at BMO Capital with analyst Daniel Salmon citing valuation and his belief that the shares will soon begin to trade based on a potential deal with Viacom (VIA, VIAB). 2. Abercrombie & Fitch (ANF) downgraded to Sell from Hold at Deutsche Bank with analyst Tiffany Kanaga saying the Abercrombie brand turnaround is yet to gain traction. 3. Twitter (TWTR) downgraded to Negative from Mixed at OTR Global. 4. HP Inc. (HPQ) downgraded to Hold from Buy at Jefferies with analyst James Kisner citing valuation and secular challenges for the downgrade. 5. First Solar (FSLR) downgraded to Neutral from Outperform at Macquarie with analyst Gurpreet Gujral citing a lack of catalysts after the company canceled the Series 5 product that was originally scheduled to launch in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

CBS

CBS

$60.06

-0.87 (-1.43%)

ANF

Abercrombie & Fitch

$15.19

-0.3 (-1.94%)

TWTR

Twitter

$18.19

-0.44 (-2.36%)

HPQ

HP Inc.

$15.24

-0.71 (-4.45%)

FSLR

First Solar

$29.66

0.28 (0.95%)

  • 30

    Nov

  • 05

    Dec

  • 12

    Dec

CBS CBS
$60.06

-0.87 (-1.43%)

11/23/16
BMOC
11/23/16
DOWNGRADE
BMOC
Market Perform
CBS downgraded on valuation, deal outlook at BMO Capital
As noted earlier, BMO Capital downgraded CBS (CBS) to Market Perform from Outperform. Analyst Daniel Salmon downgraded the stock based on valuation and his belief that the shares will soon begin to trade based on a potential deal with Viacom (VIA, VIAB). Target $63.
11/23/16
BMOC
11/23/16
DOWNGRADE
BMOC
Market Perform
CBS downgraded to Market Perform from Outperform at BMO Capital
11/14/16
BMUR
11/14/16
DOWNGRADE
BMUR
Hold
Viacom downgraded to Hold from Buy at Brean Capital
Brean Capital analyst Alan Gould downgraded Viacom (VIAB) to Hold with a fair value estimate for shares of $40. The analyst questions the "true synergies" between Viacom and CBS (CBS) and believes combining the two companies does not maximize value. Viacom closed Friday up 41c to $38.42.
11/15/16
FBRC
11/15/16
DOWNGRADE
Target $44
FBRC
Market Perform
Viacom downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Barton Crockett downgraded Viacom (VIAB) to Market Perform saying he sees a better risk/reward in CBS (CBS) until the "merger noise is cleared." The analyst lowered his price target for Viacom shares to $44 from $56.
ANF Abercrombie & Fitch
$15.19

-0.3 (-1.94%)

11/23/16
DBAB
11/23/16
DOWNGRADE
Target $13
DBAB
Sell
Abercrombie & Fitch downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Tiffany Kanaga downgraded Abercrombie & Fitch (ANF) to Sell saying the Abercrombie brand turnaround is yet to gain traction. In a research note partially titled "Pre-Thanksgiving Rally Full of Stuffing, Not Meat," Kanaga writes that she expects a "prolonged recovery" for the Abercrombie brand. American Eagle (AEO) remains her preferred way to play the teen apparel space. The analyst cut her price target for Abercrombie shares to $13 from $14. The retailer closed yesterday up 73c to $15.49.
11/21/16
BOFA
11/21/16
NO CHANGE
Target $10
BOFA
Underperform
Abercrombie on track to trigger debt prepayment penalty, says BofA/Merrill
BofA/Merrill analyst Stephen Albert said Abercrombie & Fitch is on track to trigger a mandatory debt prepayment penalty at year end if current business trends continue in Q4. The analyst said Abercrombie could finish 2016 with a Debt/EBITDA raitio of 1.34x, above the 1x ratio that triggers a prepayment penalty equal to 25% of its annual cash flow. The analyst is currently forecasting $47M of free cash flow and said it has cash to fund the dividend near-term, but believes the dividend could be at risk longer-term if trends continue to deteriorate. Albert rates Abercrombie an Underperform and lowered its price target to $10 from $12.
11/21/16
RHCO
11/21/16
NO CHANGE
RHCO
Abercrombie & Fitch outlook remains positive despite miss, says SunTrust
After Abercrombie & Fitch reported weaker than expected Q3 results, SunTrust analyst Pamela Quintiliano blames the miss on traffic weakness and excess cold weather products. However, the analyst believes that the company has "multiple initiatives" which leave it well-positioned to improve in fiscal 2017. The analyst cut her price target on the shares to $19 from $23 and reiterates a Buy rating.
11/21/16
11/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 3M (MMM) downgraded to Sell from Neutral at Goldman with analyst Joe Ritchie saying he believes 3M's "undifferentiated" organic growth driven by Electronics and Energy weakness and margin headwinds will result in shares underperformance. 2. Abercrombie & Fitch (ANF) downgraded to Underperform from Sector Perform at RBC Capital, citing the company's Q3 results and a belief that it faces multiple challenges, including macro, secular, and brand perception issues. 3. BNY Mellon (BK) downgraded to Neutral from Buy at Buckingham. 4. Foot Locker (FL) downgraded to Neutral from Overweight at Piper Jaffray with analyst Erinn Murphy saying the stock is "priced for perfection" with the company at peak operating margins. 5. Allegiant Travel (ALGT) downgraded to Peer Perform from Outperform at Wolfe Research with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TWTR Twitter
$18.19

-0.44 (-2.36%)

11/23/16
OTRG
11/23/16
DOWNGRADE
OTRG
Negative
Twitter downgraded to Negative from Mixed at OTR Global
OTR Global checks indicate Q4 year-over-year ad spending has deteriorated versus Q3.
10/28/16
10/28/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Perform from Underperform at Oppenheimer with analyst Jason Helfstein saying the stock's valuation now "properly" reflects the challenging fundamental outlook. 2. Bristol-Myers (BMY) upgraded to Long-Term Buy from Neutral at Hilliard Lyons. 3. Qualcomm (QCOM) upgraded on valuation at BMO Capital with analyst Tim Long saying he is neutral on Qualcomm's acquisition of NXP (NXPI), but he expects Qualcomm's stock to stay in a trading range in the wake of the deal. 4. Level 3 (LVTL) upgraded to Outperform from Perform at Oppenheimer with analyst Timothy Horan saying the company has restructured itself in the last few years and now has operational/financial flexibility on free cash flow, with the analyst seeing accelerating growth in 2017. 5. ConocoPhillips (COP) upgraded to Overweight from Neutral at Piper Jaffray with analyst Guy Baber saying the company reported "another solid quarter." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/10/16
LOOP
11/10/16
NO CHANGE
Target $151
LOOP
Buy
Netflix price target raised to $151 from $133 at Loop Capital
Loop Capital analyst David Miller raised his net subscriber growth assumptions for Netflix (NFLX) in 2017, taking up his domestic streaming net subscriber estimate by the end of 2017 to 53.7M from 53.6M and his end-year international net subscriber estimate to 55.8M from 54.8M. In doing so, he raised all of his income statement metrics and took up his price target accordingly to $151 from $133. Additionally, Miller contends that "simply because Twitter (TWTR) recently broadcast a few NFL games" does not mean Netflix will, or should, move into streaming sports.
11/10/16
LOOP
11/10/16
NO CHANGE
Target $16
LOOP
Hold
Bain departure a loss for Twitter, says Loop Capital
Loop Capital analyst Blake Harper said the departure of COO Adam Bain is a loss for Twitter (TWTR), noting that he is well regarded internally and within the tech and advertising industries. Twitter is now searching for a full time CFO and a head of product and CEO Jack Dorsey continues to serve as full time CEO of Square (SQ) as well, which would "appear to leave its executive team stretched thin," said Harper, who keeps a Hold rating on Twitter shares.
HPQ HP Inc.
$15.24

-0.71 (-4.45%)

08/25/16
EVER
08/25/16
NO CHANGE
EVER
Micron has positive read through from HP statements, says Evercore ISI
After Hewlett-Packard (HPQ) said, "We are seeing on the horizon some shortages, particularly around LCDs, DRAM, and flash memory.," Evercore ISI analyst C.J. Muse says that the statement is positive for Micron. The analyst keeps a $16 price target and Buy rating on Micron.
11/23/16
JEFF
11/23/16
DOWNGRADE
Target $16.75
JEFF
Hold
HP Inc. downgraded to Hold from Buy at Jefferies
Jefferies analyst James Kisner downgraded HP Inc. to Hold with a $16.75 price target following the company's Q4 results. The analyst cites valuation and secular challenges for the downgrade.
10/14/16
BMUR
10/14/16
NO CHANGE
Target $18
BMUR
Buy
HP Inc. new business model conservative, says Brean Capital
Brean Capital analyst Ananda Baruah attended the HP, Inc. analyst day and said although it didn't hold any surprises, he believes the company's new long-term business model remains conservative. The analyst said if the company can execute its model its revenue growth will have to be stronger than stated and its guidance must be conservative. Baruah reiterated his Buy rating and $18 price target on HP, Inc. shares.
08/25/16
MAXM
08/25/16
DOWNGRADE
Target $15
MAXM
Hold
HP Inc. downgraded to Hold on pressured printing margins at Maxim
As previously reported, Maxim analyst Nehal Chokshi downgraded HP Inc. to Hold from Buy and lowered his price target to $15 from $17, saying that his analysis points to sustained printing supplies pricing pressure despite the refresh of its printer hardware. Chokshi added that he expects the company to lower its FY17 earnings guidance at its Securities Analyst Meeting in October.
FSLR First Solar
$29.66

0.28 (0.95%)

11/18/16
11/18/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underperform from Market Perform at BMO Capital with analyst James Fotheringham saying that the shares don't reflect the impact of its "recent cross-selling issues." 2. Gap (GPS) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez citing expectations that the company's brands will continue to struggle. 3. Citi (C) downgraded to Neutral from Outperform at Macquarie with analyst David Konrad saying investors should shift exposure to names that have more leverage to capital markets and increased economic activity and away from global banks. 4. Torchmark (TMK) downgraded to Underperform from Neutral at BofA/Merrill with analyst Seth Weiss citing relative valuation. 5. First Solar (FSLR) downgraded to Sell from Neutral at UBS with analyst Julien Dumoulin-Smith saying the recently issued 2017 guidance "is not the trough in expectations." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/18/16
UBSW
11/18/16
DOWNGRADE
Target $25
UBSW
Sell
First Solar downgraded to Sell from Neutral at UBS
UBS analyst Julien Dumoulin-Smith downgraded First Solar to Sell saying the just issued 2017 guidance "is not the trough in expectations." The company's outlook does not "necessarily improve substantially" in 2018 and 2019 could be another peak year as ITC steps down, Dumoulin-Smith tells investors in a research note. The analyst notes that First Solar's structural cash flow "remains quite limited." He cut his price target for the shares to $25 from $45.
11/18/16
ROTH
11/18/16
NO CHANGE
Target $27
ROTH
Neutral
First Solar price target lowered to $27 from $33 at Roth Capital
Roth Capital analyst Philip Shen lowered his price target for First Solar to $27 from $33 given the uncertainty around earnings power for an extended period of time. The analyst notes that 2017 and the first half of 2018 will represent a transition period with much lower than expected earnings power as the company takes Series 4 capacity offline. He reiterates a Neutral rating on the shares.
11/23/16
MACQ
11/23/16
DOWNGRADE
Target $32.75
MACQ
Neutral
First Solar downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Gurpreet Gujral downgraded First Solar to Neutral citing a lack of catalysts after the company canceled the Series 5 product that was originally scheduled to launch in 2017. Pulling forward the launch of its Series 6 product to mid-2018 from 2019 is positive for investors in the long term, but First Solar shares lack a catalyst over the nearer term, Gujral tells investors in a research note. The analyst cut his price target for the shares to $32.75 from $57.33. First Solar closed yesterday up 28c to $29.66.

TODAY'S FREE FLY STORIES

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

FOR

Forestar Group

$13.40

0.2 (1.52%)

17:06
12/02/16
12/02
17:06
12/02/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Forestar Group »

Carlson Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

17:04
12/02/16
12/02
17:04
12/02/16
17:04
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSIR

Osiris

$5.68

0.06 (1.07%)

17:02
12/02/16
12/02
17:02
12/02/16
17:02
Hot Stocks
Osiris: Nasdaq grants company's request for additional time »

Osiris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOR

STORE Capital

$24.45

0.52 (2.17%)

17:00
12/02/16
12/02
17:00
12/02/16
17:00
Hot Stocks
STORE Capital director Donovan acquires 4,350 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARB

Carbonite

$17.95

0.25 (1.41%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
Breaking Hot Stocks news story on Carbonite »

Crosslink lowers stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIB

CGI Group

$47.11

0.16 (0.34%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
CGI Group announces specific share repurchase program »

CGI Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.